Search results
- Investing.com
Regeneron stock soars to all-time high of $1106.2 By Investing.com
This milestone underscores a period of robust growth for the biotechnology company, which has seen its shares surge by an impressive 41.7% o...
3 days ago
- Benzinga
Analyst Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals (NASDAQ:REGN)
Debt Management: Regeneron Pharmaceuticals's debt-to-equity ratio is below industry norms, indicating a sound financial...Explained Analyst ...
3 days ago